✦ LIBER ✦

Early results of a single-blinded, randomized, controlled, Internet-based multicenter trial comparing Prolene and Vypro

✍ Scribed by Sven Bringman; Timo-Jaakko Heikkinen; Staffan Wollert; Johanna Österberg; Sam Smedberg; Håkan Granlund; Stig Ramel; Göran Felländer; Bo Anderberg

Publisher: Springer
Year: 2004
Tongue: English
Weight: 410 KB
Volume: 8
Category: Article
ISSN: 1265-4906
DOI: 10.1007/s10029-003-0192-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Early results of a randomized multicente

Early results of a randomized multicenter trial comparing Prolene and VyproII mesh in bilateral endoscopic extraperitoneal hernioplast (TEP)

✍ S. Bringman; S. Wollert; J. Osterberg; T. Heikkinen 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 168 KB

Triple therapy in early active rheumatoi

Triple therapy in early active rheumatoid arthritis: A randomized, single-blind, controlled trial comparing step-up and parallel treatment strategies

✍ S. A. Saunders; H. A. Capell; A. Stirling; R. Vallance; W. Kincaid; A. D. McMaho 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 167 KB 👁 2 views

## Abstract ## Objective The Tight Control of Rheumatoid Arthritis study previously demonstrated that an intensive step‐up disease‐modifying antirheumatic drug (DMARD) treatment strategy targeting persistent disease activity was superior to routine care in the management of early rheumatoid arthri

Efficacy and safety of adalimumab in pat

Efficacy and safety of adalimumab in patients with ankylosing spondylitis: Results of a multicenter, randomized, double-blind, placebo-controlled trial

✍ Désirée van der Heijde; Alan Kivitz; Michael H. Schiff; Joachim Sieper; Ben A. C 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB 👁 2 views

Multicenter, randomized, double-blind, a

Multicenter, randomized, double-blind, active comparator and placebo-controlled trial of a corticotropin-releasing factor receptor-1 antagonist in generalized anxiety disorder

✍ Vladimir Coric; Howard H. Feldman; Dan A. Oren; Anantha Shekhar; Joseph Pultz; R 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 205 KB 👁 2 views

A 48-week, randomized, double-blind, dou

A 48-week, randomized, double-blind, double-observer, placebo-controlled multicenter trial of combination methotrexate and intramuscular gold therapy in rheumatoid arthritis: Results of the METGO study

✍ Allen J. Lehman; John M. Esdaile; Alice V. Klinkhoff; Eric Grant; Avril Fitzgera 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB 👁 3 views

Efficacy and safety of high-dose pravast

Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: Results of a prospective, randomized, double-blind, placebo-controlled, multicenter trial

✍ James H. Lewis; Mary Ellen Mortensen; Steven Zweig; Mary Jean Fusco; Jeffrey R. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB 👁 2 views

The hepatotoxic potential of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in patients with underlying chronic liver disease remains controversial. We performed a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial that compared pravastatin (80 mg) to a place